WELL Health Technologies Corp.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA94947L1022
CAD
4.34
0.03 (0.7%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
384.77
364.60
356.67
294.14
193.24
251.74
243.15
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
384.77
364.60
356.67
294.14
193.24
251.74
243.15
Raw Material Cost
230.21
225.35
223.33
196.21
173.04
156.96
153.07
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
65.44
60.87
63.98
45.53
42.19
38.59
41.02
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
16.04
17.98
12.70
11.41
9.08
8.90
9.56
Selling and Distribution Expenses
115.31
105.97
104.44
86.33
84.14
76.91
75.94
Other Expenses
-8.15
-7.88
-7.67
-5.69
-5.13
-4.75
-5.06
Total Expenditure (Excl Depreciation)
345.52
331.31
327.77
282.54
257.18
233.88
229.02
Operating Profit (PBDIT) excl Other Income
39.2
33.3
28.900000000000002
11.6
-63.9
17.9
14.1
Other Income
3.35
8.58
-0.12
-1.61
-20.44
-0.04
-1.72
Operating Profit (PBDIT)
64.90
68.39
54.18
29.54
-63.41
35.30
29.72
Interest
16.04
17.98
12.70
11.41
9.08
8.90
9.56
Exceptional Items
-7.86
-16.83
6.95
-39.32
44.30
-81.75
111.99
Gross Profit (PBDT)
154.56
139.25
133.34
97.93
20.20
94.78
90.07
Depreciation
22.30
26.52
25.39
19.55
20.96
17.48
17.31
Profit Before Tax
18.70
7.05
23.04
-40.73
-49.16
-72.83
114.84
Tax
-13.41
9.56
5.92
-1.23
-19.05
1.09
-1.96
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
22.89
4.17
12.15
-46.57
-13.00
-81.19
111.72
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
22.89
4.17
12.15
-46.57
-13.00
-81.19
111.72
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
9.11
-6.83
4.85
4.69
-18.73
5.44
5.26
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
32.00
-2.65
17.00
-41.89
-31.73
-75.75
116.98
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
863.51
844.39
826.20
834.43
867.61
847.12
935.02
Earnings per share (EPS)
0.09
0.02
0.05
-0.19
-0.05
-0.33
0.43
Diluted Earnings per share
0.09
0.02
0.05
-0.19
-0.05
-0.33
0.43
Operating Profit Margin (Excl OI)
10.2%
9.13%
8.1%
3.94%
-33.09%
7.1%
5.81%
Gross Profit Margin
10.66%
9.21%
13.58%
-7.2%
-14.59%
-21.99%
54.35%
PAT Margin
5.95%
1.14%
3.41%
-15.83%
-6.73%
-32.25%
45.95%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Dec 2025 is 99.17% vs -16.44% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Dec 2025 is 200.95% vs -193.79% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2025 is 243.02% vs -248.79% in Dec 2024

stock-summary

Interest

YoY Growth in quarter ended Dec 2025 is 75.82% vs 5.81% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024

Compare Quarterly Results Of WELL Health Technologies Corp. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CAD)
Change(%)
Net Sales
384.77
435.20
-50.43
-11.59%
Other Operating Income
0.00
0.00
0.00
Total Operating income
384.77
435.20
-50.43
-11.59%
Raw Material Cost
230.21
263.40
-33.19
-12.60%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
65.44
0.00
65.44
Power Cost
0
0
0.00
Manufacturing Expenses
16.04
21.70
-5.66
-26.08%
Selling and Distribution Expenses
115.31
139.60
-24.29
-17.40%
Other Expenses
-8.15
-2.17
-5.98
-275.58%
Total Expenditure (Excl Depreciation)
345.52
403.00
-57.48
-14.26%
Operating Profit (PBDIT) excl Other Income
39.25
32.20
7.05
21.89%
Other Income
3.35
0.20
3.15
1,575.00%
Operating Profit (PBDIT)
64.90
78.60
-13.70
-17.43%
Interest
16.04
21.70
-5.66
-26.08%
Exceptional Items
-7.86
-6.90
-0.96
-13.91%
Gross Profit (PBDT)
154.56
171.80
-17.24
-10.03%
Depreciation
22.30
46.20
-23.90
-51.73%
Profit Before Tax
18.70
3.80
14.90
392.11%
Tax
-13.41
2.90
-16.31
-562.41%
Provisions and contingencies
0
0
0.00
Profit After Tax
22.89
0.90
21.99
2,443.33%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
22.89
0.90
21.99
2,443.33%
Share in Profit of Associates
0
0
0.00
Minority Interest
9.11
0.00
9.11
Other related items
0.00
0.00
0.00
Consolidated Net Profit
32.00
0.90
31.10
3,455.56%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
863.51
1,770.60
-907.09
-51.23%
Earnings per share (EPS)
0.09
0.00
0.09
Diluted Earnings per share
0.09
0.00
0.09
Operating Profit Margin (Excl OI)
10.20%
7.40%
0.00
2.80%
Gross Profit Margin
10.66%
11.49%
0.00
-0.83%
PAT Margin
5.95%
0.21%
0.00
5.74%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 38.48 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 5.54% vs 2.21% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 99.17% vs -16.44% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 3.20 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 1,285.19% vs -115.88% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 200.95% vs -193.79% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 6.15 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 2.84% vs 10.13% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 243.02% vs -248.79% in Dec 2024

Quarterly - Interest
Interest 1.60 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -11.11% vs 41.73% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 75.82% vs 5.81% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 10.20%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024